The Impact of Ai on Clinical Trials and Healthcare Research

Abstract

Artificial intelligence, AI can rightly be said to have revolutionized the world in many ways especially in the clinical trials and healthcare research. AI is changing the approach to delivering care and actively contributing toward the discovery of effective medication, patient surveillance and trial enrollment. Thus, engaging with big data, AI provides healthcare practitioners and researchers better tools to transform big data into meaningful information and, in turn, make better decisions. Certainly, incorporating artificial intelligence tools in the clinical trial process has significantly enhanced the usefulness of these trial because they have eliminated many instances of human-made mistakes that used to affect trials results. AI’s relevance goes beyond drug development; it also helps in recruiting the right patients with efficiency and also acquisitions when patients are utilizing wearable gadgets for the collection of data. Furthermore, it helps in early identification of galloping complications as well as untailored treatment approaches during the trials. Nevertheless, the use of AI is not without its challenges when it comes to advanced clinical research for cancer. To discuss precautions that need to be taken for the utilization of AI in healthcare, some issues that need to be solved include data privacy, algorithmic bias and ethical dilemmas tied to decision-making authority. The concerns for; this means that AI solutions may bring premium and inferior services to some classes of people in society, thus leading to injustice. However, there are certain limitations to overcome which makes the path for bright for AI in clinical trials as well as health care research. These technologies will further evolve, and existing problems will be solved and hence provide a new perspective on clinical trials and potential possibilities for improved, faster, and more accurate healthcare systems.